Terms & Conditions
Last updated: 28 April 2026
These Terms and Conditions (Terms) govern your access to and use of the Creative Thinking Institute website, Regenemm Healthcare platform, Regenemm Voice, related applications, content, services, communications and digital resources.
Creative Thinking Institute Pty Ltd (CTI, we, us, our) is the AI-native parent company behind Regenemm Healthcare. Regenemm Healthcare includes clinical workflow tools, voice capture, transcription, summarisation, structured documentation, patient-facing summaries, consent-aware distribution, auditability, interoperability and related services.
These Terms are a public website and platform terms draft. They should be reviewed by qualified legal, privacy and clinical governance advisers before being relied on as the final legal position for any specific product, customer deployment, research activity, clinical workflow or jurisdiction.
1. Agreement to These Terms
By accessing or using the Website, Platform or related services, you agree to these Terms and our Privacy Policy. If you do not agree, you must not use the Website, Platform or services.
Additional terms may apply to particular products, clinical deployments, customer agreements, research activities, subscriptions, business associate agreements, data processing agreements, consent forms or service orders. If there is a conflict, the more specific written agreement will apply to the relevant service or deployment.
2. Services Covered
These Terms apply to:
- the Creative Thinking Institute website at www.creativethinkinginstitute.com;
- Regenemm Healthcare products, hubs, spokes, portals, applications and related services;
- Regenemm Voice and related voice capture, transcription, summarisation and documentation workflows;
- patient-facing summaries, letters, structured records, education documents, handover materials and clinical workflow outputs;
- research, waitlist, pilot, demo, support, implementation and educational activities; and
- any other CTI or Regenemm Healthcare services that link to these Terms.
3. Healthcare and Clinical Use
Regenemm Healthcare is designed to support clinical workflow, documentation and communication. It is not a replacement for clinical judgement, medical advice, diagnosis, treatment, escalation or emergency care.
AI-assisted outputs may include transcripts, draft clinical notes, patient summaries, letters, education materials, FHIR-ready resources, workflow suggestions or other documentation. These outputs must be reviewed, corrected and approved by appropriately qualified clinicians or authorised users before clinical reliance, sharing or use in care decisions.
Clinicians and healthcare organisations remain responsible for clinical decisions, patient care, escalation, recordkeeping obligations and compliance with professional standards.
In an emergency, users and patients should contact emergency services or seek urgent medical care.
4. Patient Consent and Authorised Sharing
Certain Regenemm workflows may involve recording consultations, generating transcripts, producing clinical documentation, creating patient-facing summaries, using de-identified information for research or analytics, and sharing information with authorised care team members.
Where required, the relevant clinician, healthcare provider, customer or deployment owner must obtain and document appropriate consent or another lawful basis before collecting, recording, processing, sharing or using patient information.
Identifiable patient information should only be shared with authorised recipients, such as treating clinicians, care team members, hospitals, electronic medical record systems, My Health Record, or other recipients, where permitted by law, consent, customer configuration and clinical workflow.
Withdrawal of consent does not affect processing that occurred lawfully before withdrawal. Some finalised clinical records, audit records or legal records may need to be retained where required for clinical, legal, audit, medicolegal or regulatory reasons.
5. AI Systems and Human Oversight
Regenemm uses AI systems, machine learning and related technologies to support tasks such as:
- voice capture and transcription;
- clinical documentation;
- de-identification and quality assurance;
- patient-facing summaries;
- structured data generation;
- clinical workflow support;
- auditability and provenance;
- research and predictive health analytics where authorised.
AI systems support human users. They do not make autonomous clinical decisions. Human review, escalation pathways, clinical accountability and appropriate governance remain central.
Users must not rely on AI-assisted outputs without appropriate review, validation and clinical judgement.
6. De-Identified Data, Research and Analytics
Where permitted by law, consent, customer agreement or research governance, CTI or Regenemm Healthcare may use de-identified, aggregated or anonymised data for research, healthcare analytics, predictive modelling, service improvement, safety monitoring, quality assurance, model evaluation and platform improvement.
De-identification means taking steps to remove or transform information that could reasonably identify an individual before use for these purposes.
We do not permit identifiable patient information to be used for third-party monetisation. De-identified research and analytics must be handled under applicable privacy, security, governance and ethical controls.
7. User Responsibilities
You agree to use the Website, Platform and services only for lawful, authorised and appropriate purposes.
You must not:
- use the Website or Platform in a way that violates applicable law, regulation, professional obligations or these Terms;
- upload, enter or share information that you do not have authority to provide;
- bypass, disable or interfere with authentication, authorisation, consent, audit, security or entitlement controls;
- attempt to access another user, patient, tenant, organisation or system without authority;
- introduce malware, malicious code, harmful prompts, prompt injection attacks, model manipulation attempts or other harmful material;
- overload, disrupt, probe, scrape, reverse engineer or attack the Website, Platform or infrastructure;
- use outputs to make clinical decisions without appropriate clinical review;
- misrepresent AI-assisted draft outputs as clinician-approved final records where they have not been reviewed;
- use the services for unlawful surveillance, discrimination, harassment or harm; or
- infringe CTI, Regenemm or third-party intellectual property rights.
8. Account Security
Where accounts are provided, you are responsible for keeping credentials secure and for activity under your account. You must promptly notify us or your organisation administrator if you suspect unauthorised access, credential compromise or misuse.
We may suspend or restrict access where we reasonably believe there is a security, privacy, clinical safety, compliance, legal or operational risk.
9. Clinical Records, Auditability and Immutability
Certain Regenemm workflows may create finalised clinical documents, audit records, provenance records, consent records or system logs. Some finalised records may be stored in write-once, immutable or audit-protected formats to preserve integrity, authenticity and medicolegal reliability.
Users must not attempt to alter, delete, falsify or obscure finalised clinical documentation, provenance records or audit trails except through authorised correction, amendment, addendum or governance processes.
10. Privacy and Data Protection
Our handling of personal information is described in our Privacy Policy. By using the Website, Platform or services, you acknowledge that information may be collected, used, disclosed, stored and protected as described in that policy and in any applicable customer agreement, consent form or deployment notice.
Privacy, security and consent obligations may differ depending on the jurisdiction, customer, clinical setting, research protocol or deployment model.
11. Security, Governance and Compliance
CTI and Regenemm Healthcare are building a governance and assurance posture across privacy, security, AI governance, clinical safety, provenance and operational controls.
This includes work with Vanta and alignment activities across ISO 27001, ISO 42001, HIPAA, GDPR and SOC 2 readiness. Unless expressly stated in writing, references to accreditation pathways, readiness or alignment do not mean certification has been formally granted.
We may implement security controls, monitoring, audit logging, identity controls, access controls, incident response processes, release gates and other safeguards. You agree not to interfere with those controls.
12. Intellectual Property and Trademarks
The Website, Platform, software, documentation, content, designs, workflows, graphics, logos, trade names, trademarks, know-how, methods, templates, prompts, architectures and related materials are owned by CTI, Regenemm Healthcare or their licensors, except where otherwise stated.
Regenemm® and the Regenemm logo are protected internationally through Madrid Protocol trademark coverage across jurisdictions including Japan, Canada, the United Kingdom, Europe, the United States, New Zealand and South Africa.
You must not copy, reproduce, modify, distribute, reverse engineer, rebrand, misuse or create derivative works from our intellectual property except as expressly authorised in writing.
13. Feedback and Suggestions
If you provide feedback, suggestions, ideas, corrections or comments, you grant CTI and Regenemm Healthcare permission to use that feedback to improve our products, services, documentation, workflows and operations without obligation to compensate you, unless otherwise agreed in writing.
Do not submit confidential, proprietary or third-party information unless you have authority to do so.
14. Third-Party Services and Links
The Website or Platform may link to or integrate with third-party services, including cloud providers, analytics providers, communication tools, authentication services, payment providers, AI infrastructure providers, healthcare systems or external websites.
We are not responsible for third-party websites or services that we do not control. Your use of third-party services may be governed by their own terms and privacy policies.
15. Availability, Changes and Suspension
We may change, suspend, withdraw, update or discontinue parts of the Website, Platform or services at any time. We may also restrict access for maintenance, security, compliance, safety, misuse, legal, operational or commercial reasons.
We will use reasonable efforts to operate services reliably, but we do not guarantee uninterrupted or error-free availability.
16. Disclaimers
To the maximum extent permitted by law, the Website, Platform and services are provided on an "as is" and "as available" basis.
We do not warrant that:
- the Website, Platform or services will be uninterrupted, error-free or always available;
- AI-assisted outputs will be complete, accurate or clinically appropriate without human review;
- defects will always be corrected immediately;
- the services will meet every user, customer, clinical, operational or regulatory requirement; or
- the Website, Platform or services will be free of all security risks.
Nothing in these Terms excludes warranties, guarantees or rights that cannot be excluded under applicable law.
17. Limitation of Liability
To the maximum extent permitted by law, CTI, Regenemm Healthcare and their officers, directors, employees, contractors and agents will not be liable for indirect, incidental, special, consequential, punitive or exemplary damages arising from use of the Website, Platform or services.
Where liability cannot be excluded, our liability is limited to the extent permitted by applicable law.
Nothing in these Terms limits liability that cannot legally be limited.
18. Indemnity
You agree to indemnify CTI and Regenemm Healthcare against claims, losses, damages, costs or expenses arising from your misuse of the Website, Platform or services, breach of these Terms, unlawful conduct, unauthorised use of information, infringement of rights, or failure to obtain required consent or authority.
19. Governing Law
These Terms are governed by the laws of Victoria, Australia, unless a specific written agreement states otherwise.
The parties submit to the non-exclusive jurisdiction of the courts of Victoria, Australia.
20. Changes to These Terms
We may update these Terms from time to time. Updated Terms will be posted on the Website or otherwise notified where required. Continued use after changes take effect means you accept the updated Terms.
21. Contact
For questions about these Terms, contact:
Creative Thinking Institute Pty Ltd
378 Victoria Parade
East Melbourne, Victoria 3002
Australia
info@creativethinkinginstitute.com
For privacy enquiries, contact privacy@creativethinkinginstitute.com.